Search
Pelthos Therapeutics Ord Shs
PTHSAdd to Watchlist
9.390USD
+0.490+5.51%
Close 11-11 16:00（ET）
36.90MMarket Cap
LossP/E TTM
About Pelthos Therapeutics Ord Shs Company
Pelthos Therapeutics Inc. is a biopharmaceutical company focused on commercializing therapeutic products for unmet patient needs. The Company's lead product, ZELSUVMI (berdazimer) topical gel, 10.3%, is used in the treatment of molluscum contagiosum infections (molluscum) in adults and pediatric patients one year of age and older. In addition to ZELSUVMI, the Company has a pipeline of product candidates that utilize its proprietary nitric oxide-based technology platform, NITRICIL. The Company’s product Xepi (ozenoxacin) Cream, 1%, which is a non-fluorinated quinolone antimicrobial indicated for the topical treatment of impetigo. The Company is also evaluating the path forward for its existing NaV 1.7 development programs for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks.
Pelthos Therapeutics Ord Shs Profile
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Pelthos Therapeutics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Ezra M. Friedberg
Mr. Ezra M. Friedberg
Independent Director
Independent Director
67.75K
-0.82%
Dr. Richard Malamut
Dr. Richard Malamut
Independent Director
Independent Director
15.72K
+33.10%
Mr. Sai Rangarao
Mr. Sai Rangarao
Chief Commercial Officer
Chief Commercial Officer
10.17K
-199.99%
Mr. Francis P. (Frank) Knuettel, II
Mr. Francis P. (Frank) Knuettel, II
Chief Financial Officer, Treasurer, Company Secretary
Chief Financial Officer, Treasurer, Company Secretary
--
--
Mr. Todd C. Davis
Mr. Todd C. Davis
Independent Director
Independent Director
--
--
Mr. Peter Greenleaf
Mr. Peter Greenleaf
Chairman of the Board
Chairman of the Board
--
--
Mr. Matthew Pauls
Mr. Matthew Pauls
Independent Director
Independent Director
--
--
Mr. Richard Baxter
Mr. Richard Baxter
Independent Director
Independent Director
--
--
Mr. Scott Plesha
Mr. Scott Plesha
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Andrew J. Einhorn
Mr. Andrew J. Einhorn
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ezra M. Friedberg
Mr. Ezra M. Friedberg
Independent Director
Independent Director
67.75K
-0.82%
Dr. Richard Malamut
Dr. Richard Malamut
Independent Director
Independent Director
15.72K
+33.10%
Mr. Sai Rangarao
Mr. Sai Rangarao
Chief Commercial Officer
Chief Commercial Officer
10.17K
-199.99%
Mr. Francis P. (Frank) Knuettel, II
Mr. Francis P. (Frank) Knuettel, II
Chief Financial Officer, Treasurer, Company Secretary
Chief Financial Officer, Treasurer, Company Secretary
--
--
Mr. Todd C. Davis
Mr. Todd C. Davis
Independent Director
Independent Director
--
--
Mr. Peter Greenleaf
Mr. Peter Greenleaf
Chairman of the Board
Chairman of the Board
--
--
FAQs
Who are the top five shareholders of Pelthos Therapeutics Ord Shs?
The top five shareholders of Pelthos Therapeutics Ord Shs are: Mr. Ezra M. Friedberg